SCHEMBL14517867

SCHEMBL14517867

C=CCn1c(=O)c2[nH]c(-c3cc(OCC(=O)Nc4ccc5c(c4)OCO5)no3)nc2n(CC=C)c1=O

nearest known ligand 0.79

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 19/20 0.79
▸ ADORA1 P30542 8/20 0.61
▸ ADORA2A P29274 2/20 0.61
▸ ALDH1A1 P00352 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780170 0.88 ADORA2B (1.00) ADORA2BADORA1ADORA2A
SCHEMBL14517874 0.86 ADORA2B (0.82) ADORA2BADORA1ADORA2A
SCHEMBL1222451 0.76 ADORA2B (1.00) ADORA2BADORA1ADORA2A
SCHEMBL14293825 0.76 ADORA2B (0.81) ADORA2BADORA1ADORA2A
SCHEMBL1782085 0.75 ADORA2B (0.67) ADORA2BADORA1ADORA2AALDH1A1
SCHEMBL1780810 0.74 ADORA2B (1.00) ADORA2BADORA1ADORA2AADORA3
SCHEMBL1781047 0.74 ADORA2B (1.00) ADORA2BADORA1ADORA2A
SCHEMBL1779300 0.74 ADORA2B (1.00) ADORA2BADORA1ADORA2AADORA3
SCHEMBL4758458 0.67 ADORA2B (1.00) ADORA2BADORA1ADORA2AADORA3
SCHEMBL12265177 0.65 ADORA2B (0.58) ADORA2BADORA1ADORA2AALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205403-B2 8-Heteroaryl xanthine adenosine A2B receptor antagonists KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) 2007-04-17 — — US disclosed
US-7205403-B2 8-Heteroaryl xanthine adenosine A2B receptor antagonists KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) 2007-04-17 — — US disclosed
Send feedback